N4-BENZOYL-3'-DEOXYCYTIDINE manufacturers
|
| N4-BENZOYL-3'-DEOXYCYTIDINE Basic information |
Product Name: | N4-BENZOYL-3'-DEOXYCYTIDINE | Synonyms: | N4-Benzoyl-3'-deoxycytidine;N4-Benzoyl-3'-deoxy-D-cytidine;N-(1-((2R,3R,5S)-3-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide;Cytidine, N-benzoyl-3'-deoxy- (9CI);N-?benzoyl-?3'-?deoxy-(9CI)Cytidine;N4-Benzoyl-3'-deoxycytidine;N4-Benzoyl-3′-deoxycytidine, CAS 161110-00-5 | CAS: | 161110-00-5 | MF: | C16H17N3O5 | MW: | 331.32 | EINECS: | | Product Categories: | | Mol File: | 161110-00-5.mol |  |
| N4-BENZOYL-3'-DEOXYCYTIDINE Chemical Properties |
density | 1.50±0.1 g/cm3(Predicted) | pka | 8.65±0.20(Predicted) |
| N4-BENZOYL-3'-DEOXYCYTIDINE Usage And Synthesis |
Chemical Properties | White to off-white crystalline powder | Uses | N4-Benzoyl-3’-deoxycytidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| N4-BENZOYL-3'-DEOXYCYTIDINE Preparation Products And Raw materials |
|